BRPI0822485A2 - Composição farmacêutica para prevenção de disbiose associada com administração enteral de antibióticos. - Google Patents
Composição farmacêutica para prevenção de disbiose associada com administração enteral de antibióticos.Info
- Publication number
- BRPI0822485A2 BRPI0822485A2 BRPI0822485-4A BRPI0822485A BRPI0822485A2 BR PI0822485 A2 BRPI0822485 A2 BR PI0822485A2 BR PI0822485 A BRPI0822485 A BR PI0822485A BR PI0822485 A2 BRPI0822485 A2 BR PI0822485A2
- Authority
- BR
- Brazil
- Prior art keywords
- antibiotics
- prevention
- pharmaceutical composition
- enteral administration
- dysbiosis associated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/RU2008/000151 WO2009116886A1 (ru) | 2008-03-18 | 2008-03-18 | Фармацевтическая композиция и способ профилактики дисбиозов, ассоциированных с энтеральным приемом антибиотиков |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0822485A2 true BRPI0822485A2 (pt) | 2015-06-16 |
Family
ID=41091125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0822485-4A BRPI0822485A2 (pt) | 2008-03-18 | 2008-03-18 | Composição farmacêutica para prevenção de disbiose associada com administração enteral de antibióticos. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20110200668A1 (pt) |
| EP (1) | EP2266582B1 (pt) |
| CN (1) | CN101998859B (pt) |
| BR (1) | BRPI0822485A2 (pt) |
| DK (1) | DK2266582T3 (pt) |
| EA (1) | EA020023B1 (pt) |
| ES (1) | ES2542879T3 (pt) |
| HR (1) | HRP20150811T1 (pt) |
| HU (1) | HUE025097T2 (pt) |
| PL (1) | PL2266582T3 (pt) |
| PT (1) | PT2266582E (pt) |
| UA (1) | UA98215C2 (pt) |
| WO (1) | WO2009116886A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2822497C (en) | 2010-12-31 | 2020-07-28 | Abbott Laboratories | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
| US9539269B2 (en) | 2010-12-31 | 2017-01-10 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
| EP2734210B1 (en) * | 2011-07-22 | 2017-11-22 | Abbott Laboratories | Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
| MY169326A (en) | 2011-08-29 | 2019-03-21 | Abbott Lab | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
| WO2013087319A2 (de) | 2011-12-13 | 2013-06-20 | Henkel Ag & Co. Kgaa | Zusammensetzungen zur färbung keratinhaltiger fasern |
| GB201305708D0 (en) * | 2013-03-28 | 2013-05-15 | Clasado Inc | Novel use |
| CN108186661A (zh) * | 2017-12-15 | 2018-06-22 | 哈尔滨珍宝制药有限公司 | 一种包含盐酸克林霉素的药物组合物及其制备方法 |
| RU2675631C1 (ru) * | 2018-10-02 | 2018-12-21 | Общество с ограниченной ответственностью "Новые Биомедицинские Решения" | Местное гемостатическое средство с повышенной антимикробной активностью |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5861172A (en) * | 1991-05-08 | 1999-01-19 | Laboratorios Beecham Sa | Pharmaceutical formulations of compacted granulates of β-lactam antibiotics |
| IT1271449B (it) * | 1993-04-28 | 1997-05-28 | Inalco Spa | Procedimento per la preparazione di lattulosio cristallino da sciroppi commerciali |
| US5827526A (en) * | 1995-07-11 | 1998-10-27 | Abbott Laboratories | Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans |
| US6461607B1 (en) * | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
| EP1166800B1 (en) | 2000-06-28 | 2006-03-22 | B.S.D. BIO SCIENCE DEVELOPMENT SNC Di OMINI C. & ZUCCARI G. | Pharmaceutical compositions containing antibiotics and fructan mixtures |
| US8227448B2 (en) * | 2000-12-27 | 2012-07-24 | N.V. Nutricia | Nutritional composition with health promoting action containing oligosaccharides |
| NZ532707A (en) * | 2001-12-21 | 2006-07-28 | Pfizer Prod Inc | Directly compressible formulations of azithromycin |
| ITBO20020564A1 (it) * | 2002-09-06 | 2004-03-07 | Alfa Wassermann Spa | Bifidobatteri e preparazioni che li contengono. |
| RU2284832C2 (ru) * | 2004-08-30 | 2006-10-10 | Николай Александрович Киселев | Антимикробная композиция для перорального введения |
-
2008
- 2008-03-18 BR BRPI0822485-4A patent/BRPI0822485A2/pt not_active Application Discontinuation
- 2008-03-18 HU HUE08873434A patent/HUE025097T2/en unknown
- 2008-03-18 PT PT88734348T patent/PT2266582E/pt unknown
- 2008-03-18 WO PCT/RU2008/000151 patent/WO2009116886A1/ru active Application Filing
- 2008-03-18 CN CN200880128127.4A patent/CN101998859B/zh not_active Expired - Fee Related
- 2008-03-18 EP EP08873434.8A patent/EP2266582B1/en not_active Not-in-force
- 2008-03-18 UA UAA201011851A patent/UA98215C2/ru unknown
- 2008-03-18 US US12/736,167 patent/US20110200668A1/en not_active Abandoned
- 2008-03-18 ES ES08873434.8T patent/ES2542879T3/es active Active
- 2008-03-18 EA EA201001099A patent/EA020023B1/ru not_active IP Right Cessation
- 2008-03-18 DK DK08873434.8T patent/DK2266582T3/en active
- 2008-03-18 PL PL08873434T patent/PL2266582T3/pl unknown
-
2015
- 2015-07-27 HR HRP20150811TT patent/HRP20150811T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20150811T1 (hr) | 2015-09-11 |
| EA201001099A1 (ru) | 2011-02-28 |
| WO2009116886A1 (ru) | 2009-09-24 |
| CN101998859B (zh) | 2014-03-05 |
| US20110200668A1 (en) | 2011-08-18 |
| CN101998859A (zh) | 2011-03-30 |
| EP2266582A4 (en) | 2011-03-02 |
| EP2266582A1 (en) | 2010-12-29 |
| PL2266582T3 (pl) | 2015-10-30 |
| ES2542879T3 (es) | 2015-08-12 |
| UA98215C2 (ru) | 2012-04-25 |
| EP2266582B1 (en) | 2015-04-29 |
| HUE025097T2 (en) | 2016-01-28 |
| DK2266582T3 (en) | 2015-07-27 |
| EA020023B1 (ru) | 2014-08-29 |
| PT2266582E (pt) | 2015-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275854A (en) | Pharmaceutical composition and its administration | |
| BRPI0822485A2 (pt) | Composição farmacêutica para prevenção de disbiose associada com administração enteral de antibióticos. | |
| HK1164059A1 (en) | Compositions for drug administration | |
| DK1983964T3 (da) | Anordning til indgivelse af lægemiddel | |
| WO2009074300A8 (en) | Hedgehog pathway antagonists and therapeutic applications thereof | |
| IL204844A (en) | Coinolone analogues, pharmaceuticals containing them and their uses | |
| IL206808A (en) | Indolyl-pyridone history, their pharmaceutical preparations and their uses | |
| BRPI1014865A2 (pt) | "composição e formulação farmacêutica comreendendo derivados de nitrocatecol, e, método para fabricar uma composição ou formulação farmacêutica" | |
| BRPI0809661A2 (pt) | Composição farmacêutica estabilizada contendo pregabalina | |
| BR112012003800A2 (pt) | composição, peptídeo, e formulação farmacêutica. | |
| DK2482881T3 (da) | Mekanisme til indretning til indlevering af lægemiddel | |
| BRPI0817833A2 (pt) | Composição farmacêutica antimalárica | |
| BRPI1009823A2 (pt) | "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit." | |
| BRPI1007484A2 (pt) | composição farmacêutica para administração oral | |
| BRPI0914971A2 (pt) | composições farmacêuticas que contêm fármaco antibiótico de fluoroquinolonas | |
| BRPI0812234A2 (pt) | Composto de quinolona e composição farmacêutica. | |
| CR20130174A (es) | Sistema y composiciones mejorados para la administración transbucal de fármacos | |
| IL197732A0 (en) | Packaging system for pharmaceutical compositions for intravenous administration and kits comprising the same | |
| IL208788A (en) | Pharmacy-based formulation | |
| BRPI0923675A2 (pt) | formulação para administração de medicamento com baixa quantidade de lipídeos por via transmucosal oral | |
| BRPI0922888A2 (pt) | administração combinada de fármaco | |
| BR112012021455A2 (pt) | formulação farmacêutica ou nutracêutica. | |
| WO2010099510A3 (en) | Amino acid-based compounds, their methods of use, and methods of screening | |
| CL2008000092A1 (es) | Compuestos derivados de 3-cianopiridina, inhibidores del receptor p2y12; composicion farmaceutica que comprende a dichos compustos; y su uso en el tratamiento del transtorno de la agregacion plaquetaria. | |
| EP2086524A4 (en) | TRANSNASAL ANTICONVULSIVE PHARMACEUTICAL COMPOSITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |